BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp trimmed its holdings in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 5.8% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 346,119 shares of the company’s stock after selling 21,272 shares during the quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp owned 0.06% of Express Scripts worth $21,916,000 at the end of the most recent reporting period.
Several other large investors have also modified their holdings of the stock. Dodge & Cox grew its position in Express Scripts by 25.7% in the 2nd quarter. Dodge & Cox now owns 36,188,517 shares of the company’s stock valued at $2,310,275,000 after acquiring an additional 7,388,021 shares in the last quarter. Macquarie Group Ltd. grew its position in Express Scripts by 8.4% in the 2nd quarter. Macquarie Group Ltd. now owns 11,880,919 shares of the company’s stock valued at $758,480,000 after acquiring an additional 922,406 shares in the last quarter. Northern Trust Corp grew its position in Express Scripts by 12.2% in the 2nd quarter. Northern Trust Corp now owns 11,068,777 shares of the company’s stock valued at $706,629,000 after acquiring an additional 1,206,980 shares in the last quarter. Veritas Asset Management LLP grew its position in Express Scripts by 5.6% in the 3rd quarter. Veritas Asset Management LLP now owns 8,652,910 shares of the company’s stock valued at $547,902,000 after acquiring an additional 460,338 shares in the last quarter. Finally, Nordea Investment Management AB grew its position in Express Scripts by 2.6% in the 3rd quarter. Nordea Investment Management AB now owns 7,304,973 shares of the company’s stock valued at $462,551,000 after acquiring an additional 188,528 shares in the last quarter. 88.44% of the stock is owned by hedge funds and other institutional investors.
Shares of Express Scripts Holding Company (NASDAQ ESRX) opened at $68.57 on Thursday. The company has a quick ratio of 0.61, a current ratio of 0.73 and a debt-to-equity ratio of 0.86. Express Scripts Holding Company has a 52 week low of $55.80 and a 52 week high of $76.38. The firm has a market capitalization of $38,603.98, a P/E ratio of 9.96, a price-to-earnings-growth ratio of 1.01 and a beta of 0.88.
In other Express Scripts news, VP Phyllis S. Anderson sold 578 shares of the business’s stock in a transaction that occurred on Friday, September 8th. The stock was sold at an average price of $63.13, for a total value of $36,489.14. Following the completion of the sale, the vice president now owns 10,530 shares in the company, valued at $664,758.90. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Woodrow A. Myers, Jr. sold 3,900 shares of the business’s stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $63.93, for a total value of $249,327.00. Following the completion of the sale, the director now owns 11,500 shares of the company’s stock, valued at approximately $735,195. The disclosure for this sale can be found here. In the last quarter, insiders sold 5,121 shares of company stock valued at $325,920. 0.68% of the stock is owned by company insiders.
Several research firms have weighed in on ESRX. ValuEngine raised Express Scripts from a “hold” rating to a “buy” rating in a research report on Monday. TheStreet raised Express Scripts from a “c+” rating to a “b-” rating in a research report on Monday. Sanford C. Bernstein raised Express Scripts from an “underperform” rating to a “market perform” rating in a research report on Wednesday. Robert W. Baird lifted their target price on Express Scripts from $57.00 to $59.00 and gave the company a “neutral” rating in a research report on Wednesday, October 25th. Finally, Royal Bank Of Canada started coverage on Express Scripts in a research report on Tuesday, September 19th. They set a “sector perform” rating and a $68.00 price objective for the company. Six investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $70.67.
COPYRIGHT VIOLATION NOTICE: This piece of content was posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this piece of content on another website, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The correct version of this piece of content can be accessed at https://www.chaffeybreeze.com/2017/12/07/express-scripts-holding-company-esrx-position-lessened-by-british-columbia-investment-management-corp.html.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.